| Authors: |
Andrada E; Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB-CSIC), E-28049 Madrid, Spain., Almena M; Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB-CSIC), E-28049 Madrid, Spain., de Guinoa JS; Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB-CSIC), E-28049 Madrid, Spain., Merino-Cortes SV; Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB-CSIC), E-28049 Madrid, Spain., Liébana R; Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB-CSIC), E-28049 Madrid, Spain., Arcos R; Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB-CSIC), E-28049 Madrid, Spain., Carrasco S; Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB-CSIC), E-28049 Madrid, Spain., Carrasco YR; Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB-CSIC), E-28049 Madrid, Spain., Merida I; Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB-CSIC), E-28049 Madrid, Spain. imerida@cnb.csic.es. |